Armando Lunello
Medical Head Solid Tumors at Novartis Italia | Milan, Lombardy, Italy
Armando Lunello’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
ContactOut Insights • AI Generated
Armando Lunello serves as Medical Head of Solid Tumors at Novartis Italia, where he directs medical strategy, organizational transformation, and launch excellence initiatives across the Italian pharmaceutical sector. He holds his primary education from SDA Bocconi and coordinates efforts from Milan to support a global corporation employing roughly 125,000 professionals in 155 markets. His expertise bridges clinical science and commercial execution to accelerate patient access to targeted oncology therapies.
BEST APPROACH TO REACH Armando Lunello
Reach out through his personal email or direct phone line by proposing a brief call focused on how your products or strategic partnerships can directly support Novartis’s upcoming solid tumor launch roadmap in Italy.
Medical Head Solid Tumors at Novartis Italia in June 2025 - Present
Global Medical Director Immunology & Rare Diseases at Alfasigma in May 2024 - June 2025
Global Therapeutic Area Head Gastroenterology at Alfasigma in August 2023 - May 2024
Medical Affairs Manager Immunology at The Janssen Pharmaceutical Companies of Johnson & Johnson in December 2020 - August 2023
Medical Science Liaison Immunology at Sanofi Genzyme in January 2019 - December 2020
Medical Science Liaison at Chiesi Italia in April 2017 - January 2019
Libero Professionista at Centro Medico Lunello in January 2012 - April 2017
SDA Bocconi, Amministrazione e gestione aziendale, October 2026
MIP Politecnico di Milano, Amministrazione e gestione aziendale, October 2026
Seconda Università degli Studi di Napoli, Laurea Specialistica, October 2026
La nostra mission è scoprire nuovi modi per migliorare e prolungare la vita delle persone. Ci basiamo sull’ innovazione scientifica per affrontare le maggiori sfide in ambito sanitario: scopriamo e sviluppiamo trattamenti innovativi, identificando nuove modalità per far sì che raggiungano più persone possibili. Novartis ha sede a Basilea, in Svizzera. Le aziende del nostro Gruppo impiegano circa 125.000 collaboratori e i nostri prodotti sono disponibili in 155 Paesi in tutto il mondo. La capacità di attrarre, coltivare e mantenere i talenti è vitale per continuare a sviluppare prodotti innovativi in grado di offrire ai pazienti i migliori risultati. Leggi le linee guida della nostra community: https://www.novartis.com/sites/www.novartis.com/files/linkedin-community-guidelines.pdf
Discover more about Novartis Italia
Chimico-farmaceutico
Embrace Advisor at Novartis Italia
(February 2024 – Present)
Regional Access and Partnership Lead, Novartis Italia
Regional Access and Partnership Lead at Novartis Italia
(January 2022 – Present)
Medical Affairs Novartis
Teacher at ISTUM – Istituto di Studi di Management
(November 2025 – Present)
CRA @ Novartis
Clinical Research Associate at Novartis Italia
(January 2024 – Present)
Area Manager at Novartis
Area Manager Embrace at Novartis Italia
(September 2023 – Present)
Record to Report Lead @ Novartis Italia | Financial, Reporting and Accounting | Chartered Accountant and Statutory Auditor
Record to Report Lead | Financial, Reporting and Accounting at Novartis Italia
(October 2023 – Present)
What is Armando Lunello email address?
Email Armando Lunello at [email protected] and [email protected]. This email is the most updated Armando Lunello's email found in 2026.
What is Armando Lunello phone number?
Armando Lunello phone number is +393381790947.
How to contact Armando Lunello?
To contact Armando Lunello send an email to [email protected] or [email protected]. If you want to call Armando Lunello try calling on +393381790947. (updated on April 05, 2026)
What company does Armando Lunello work for?
Armando Lunello works for Novartis Italia.
What is Armando Lunello's role at Novartis Italia?
Armando Lunello is Medical Head Solid Tumors
What industry does Armando Lunello work in?
Armando Lunello works in the Pharmaceuticals industry.
